SCHEMBL27048383

SCHEMBL27048383

c1ccc(C2c3[nH]c4ccccc4c3C(c3ccccc3)c3[nH]c4ccccc4c32)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 2/20 0.68
CYP2D6 P10635 2/20 0.47
HTR7 P34969 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
ALDH1A1 P00352 2/20 0.44
GPR3 P46089 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
LMNA P02545 2/20 0.41
HTT P42858 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
HTR2A P28223 2/20 0.40
KCNH2 Q12809 2/20 0.40
HTR2C P28335 1/20 0.40
AHR P35869 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27047858 0.85 PLAU (0.56) PLAUCYP2D6HTR7CYP3A4CYP2C19
SCHEMBL27048636 0.85 PLAU (0.56) PLAUALDH1A1GPR3HSD17B10HTT
SCHEMBL27046291 0.81 PLAU (0.52) PLAUCYP2D6HTR7CYP3A4CYP2C19
SCHEMBL27047857 0.81 PLAU (0.56) PLAUHTR7MAPTMEN1KMT2A
SCHEMBL27048579 0.79 PLAU (0.54) PLAUCYP2D6HTR7CYP3A4CYP2C19
SCHEMBL27047949 0.79 PLAU (0.54) PLAUHTR7ALDH1A1GPR3HSD17B10
SCHEMBL27047922 0.78 PLAU (0.52) PLAUHTR7ALDH1A1GPR3HSD17B10
SCHEMBL27048655 0.78 PLAU (0.52) PLAUCYP2D6HTR7CYP3A4CYP2C19
SCHEMBL27047853 0.74 PLAU (0.49) PLAUALDH1A1GPR3HSD17B10LMNA
SCHEMBL17871279 0.74 CYP2D6 (0.46) PLAUCYP2D6HTR7CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025909-A1 COMPOUND AND COMPOSITION ADEKA CORPORATION (JP) 2024-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240025909-A1 COMPOUND AND COMPOSITION C5, C1R, HEATR1 PLAU 4798/4885CYP2D6 969/4885HTR7 264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.